Rybelsus Semaglutide 3mg 7mg 14mg Tablet, Packaging size: 1 x 10 Tablets

Rybelsus Tablets contain semaglutide, an oral GLP-1 receptor agonist used for the management of type 2 diabetes mellitus. It enhances glucose-dependent insulin secretion, suppresses glucagon release, delays gastric emptying, and reduces appetite. This dual action lowers blood glucose, supports weight reduction, and decreases cardiovascular risk. Therapeutically, it is indicated for adults with type 2 diabetes to improve glycemic control when diet and exercise are insufficient. Clinically, it helps prevent complications such as nephropathy, retinopathy, heart attack, and stroke, while improving metabolic outcomes and quality of life.For best results, Rybelsus may be used in combination with semaglutide injections under the guidance of your healthcare provider. Always consult your physician before making any changes to your diabetes or weight management plan. For semaglutide injections, please contact us to discuss your options.